Registry for patients with cardiomyopathy and myocarditis
Rajaie Cardiomyopathy and Myocarditis Registry
This study is collecting information from people with different types of cardiomyopathy and myocarditis to understand their conditions better and improve treatment and care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 6000 (estimated) |
| Ages | 1 Year and up |
| Sex | All |
| Sponsor | Rajaie Cardiovascular Medical and Research Center Academic / other |
| Locations | 1 site (Tehran) |
| Trial ID | NCT04304118 on ClinicalTrials.gov |
What this trial studies
This observational registry collects data from patients with various subtypes of cardiomyopathy, including hypertrophic, dilated, arrhythmogenic right ventricular, and restrictive cardiomyopathy, as well as myocarditis. The study aims to determine the clinical characteristics, natural history, treatment responses, and long-term outcomes of these patients. Additionally, it seeks to enhance prognostication through the use of artificial intelligence to predict mortality and treatment responses. The registry will address existing evidence gaps to improve patient care in cardiomyopathy and myocarditis.
Who should consider this trial
Good fit: Ideal candidates include individuals over one year old with documented cardiomyopathy or myocarditis who can provide informed consent.
Not a fit: Patients who do not consent to participate in the study will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved prognostication and treatment strategies for patients with cardiomyopathy and myocarditis.
How similar studies have performed: While observational registries are common, the specific use of artificial intelligence for prognostication in this context is a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age greater than one year 2. documented cardiomyopathy/ myocarditis fulfilling standard diagnostic criteria 3. able to give informed consent or in the case of child consent from a parent Exclusion Criteria: Patients who have not consent to participate in the study.
Where this trial is running
Tehran
- Behshid Ghadrdoost — Tehran, Iran, Islamic Republic of (Recruiting)
Study contacts
- Study coordinator: Behshid Ghadrdoost, PhD
- Email: behshid.ghadrdoost@yahoo.com
- Phone: +982123923017
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.